319 related articles for article (PubMed ID: 23372112)
1. Determinants of antiretroviral therapy initiation and treatment outcomes for people living with HIV in Vietnam.
Tran DA; Shakeshaft A; Ngo AD; Mallitt KA; Wilson D; Doran C; Zhang L
HIV Clin Trials; 2013; 14(1):21-33. PubMed ID: 23372112
[TBL] [Abstract][Full Text] [Related]
2. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
3. When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.
; Cain LE; Logan R; Robins JM; Sterne JA; Sabin C; Bansi L; Justice A; Goulet J; van Sighem A; de Wolf F; Bucher HC; von Wyl V; Esteve A; Casabona J; del Amo J; Moreno S; Seng R; Meyer L; Perez-Hoyos S; Muga R; Lodi S; Lanoy E; Costagliola D; Hernan MA
Ann Intern Med; 2011 Apr; 154(8):509-15. PubMed ID: 21502648
[TBL] [Abstract][Full Text] [Related]
4. Response to combined antiretroviral therapy according to gender and origin in a cohort of naïve HIV-infected patients: GESIDA-5808 study.
Pérez-Molina JA; Mora Rillo M; Suárez-Lozano I; Casado-Osorio JL; Teira Cobo R; Rivas González P; Pedrol Clotet E; Hernando-Jerez A; Domingo P; Barquilla Díaz E; Esteban H; González-García J;
HIV Clin Trials; 2012; 13(3):131-41. PubMed ID: 22592093
[TBL] [Abstract][Full Text] [Related]
5. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
; Judd A; Chappell E; Turkova A; Le Coeur S; Noguera-Julian A; Goetghebuer T; Doerholt K; Galli L; Pajkrt D; Marques L; Collins IJ; Gibb DM; González Tome MI; Navarro M; Warszawski J; Königs C; Spoulou V; Prata F; Chiappini E; Naver L; Giaquinto C; Thorne C; Marczynska M; Okhonskaia L; Posfay-Barbe K; Ounchanum P; Techakunakorn P; Kiseleva G; Malyuta R; Volokha A; Ene L; Goodall R
PLoS Med; 2018 Jan; 15(1):e1002491. PubMed ID: 29381702
[TBL] [Abstract][Full Text] [Related]
6. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
7. Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.
Mocroft A; Ledergerber B; Zilmer K; Kirk O; Hirschel B; Viard JP; Reiss P; Francioli P; Lazzarin A; Machala L; Phillips AN; Lundgren JD;
AIDS; 2007 Sep; 21(14):1867-75. PubMed ID: 17721094
[TBL] [Abstract][Full Text] [Related]
8. Determinants of virological failure after 1 year's antiretroviral therapy in Vietnamese people with HIV: findings from a retrospective cohort of 13 outpatient clinics in six provinces.
Tran DA; Wilson DP; Shakeshaft A; Ngo AD; Doran C; Zhang L
Sex Transm Infect; 2014 Nov; 90(7):538-44. PubMed ID: 24619575
[TBL] [Abstract][Full Text] [Related]
9. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.
Mills EJ; Bakanda C; Birungi J; Chan K; Ford N; Cooper CL; Nachega JB; Dybul M; Hogg RS
Ann Intern Med; 2011 Aug; 155(4):209-16. PubMed ID: 21768555
[TBL] [Abstract][Full Text] [Related]
10. Risk factors affecting the mortality of HIV-infected patients with pulmonary tuberculosis in the cART era: a retrospective cohort study in China.
Ji YJ; Liang PP; Shen JY; Sun JJ; Yang JY; Chen J; Qi TK; Wang ZY; Song W; Tang Y; Liu L; Zhang RF; Shen YZ; Lu HZ
Infect Dis Poverty; 2018 Mar; 7(1):25. PubMed ID: 29587840
[TBL] [Abstract][Full Text] [Related]
11. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
[TBL] [Abstract][Full Text] [Related]
12. Frequency, determinants and consequences of delayed access to care for HIV infection in France.
Lanoy E; Mary-Krause M; Tattevin P; Perbost I; Poizot-Martin I; Dupont C; Costagliola D;
Antivir Ther; 2007; 12(1):89-96. PubMed ID: 17503752
[TBL] [Abstract][Full Text] [Related]
13. The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy.
Di Biagio A; Rusconi S; Marzocchetti A; Signori A; Schiavetti I; Bruzzone B; Monno L; Punzi G; Colao MG; Penco G; Zazzi M; De Luca A;
J Med Virol; 2014 Oct; 86(10):1648-55. PubMed ID: 25042976
[TBL] [Abstract][Full Text] [Related]
14. Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care.
Sobrino-Vegas P; Rodríguez-Urrego J; Berenguer J; Caro-Murillo AM; Blanco JR; Viciana P; Moreno S; Bernardino I; del Amo J;
Antivir Ther; 2012; 17(1):1-8. PubMed ID: 22267463
[TBL] [Abstract][Full Text] [Related]
15. Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up.
Lin KY; Cheng CY; Li CW; Yang CJ; Tsai MS; Liu CE; Lee YT; Tang HJ; Wang NC; Lin TY; Lee YC; Lin SP; Huang YS; Zhang JY; Ko WC; Cheng SH; Hung CC;
PLoS One; 2017; 12(6):e0179870. PubMed ID: 28665938
[TBL] [Abstract][Full Text] [Related]
16. European mitochondrial haplogroups are associated with CD4+ T cell recovery in HIV-infected patients on combination antiretroviral therapy.
Guzmán-Fulgencio M; Berenguer J; Micheloud D; Fernández-Rodríguez A; García-Álvarez M; Jiménez-Sousa MA; Bellón JM; Campos Y; Cosín J; Aldámiz-Echevarría T; Catalán P; López JC; Resino S
J Antimicrob Chemother; 2013 Oct; 68(10):2349-57. PubMed ID: 23749950
[TBL] [Abstract][Full Text] [Related]
17. Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.
Spillane H; Nicholas S; Tang Z; Szumilin E; Balkan S; Pujades-Rodriguez M
Trop Med Int Health; 2012 Oct; 17(10):1255-63. PubMed ID: 22863110
[TBL] [Abstract][Full Text] [Related]
18. Reduced renal function is associated with progression to AIDS but not with overall mortality in HIV-infected Kenyan adults not initially requiring combination antiretroviral therapy.
Gupta SK; Ong'or WO; Shen C; Musick B; Goldman M; Wools-Kaloustian K
J Int AIDS Soc; 2011 Jun; 14():31. PubMed ID: 21663693
[TBL] [Abstract][Full Text] [Related]
19. Determinants of AIDS and non-AIDS related mortality among people living with HIV in Shiraz, southern Iran: a 20-year retrospective follow-up study.
Gheibi Z; Shayan Z; Joulaei H; Fararouei M; Beheshti S; Shokoohi M
BMC Infect Dis; 2019 Dec; 19(1):1094. PubMed ID: 31888541
[TBL] [Abstract][Full Text] [Related]
20. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy.
Paton NI; Sangeetha S; Earnest A; Bellamy R
HIV Med; 2006 Jul; 7(5):323-30. PubMed ID: 16945078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
